Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myadec is a high-potency multivitamin and mineral supplement marketed as a consumer healthcare product. It is formulated to provide a comprehensive range of essential micronutrients, including vitamins A, C, D, E, and the B-complex series, along with minerals such as iron, zinc, iodine, magnesium, and copper. These components serve as vital cofactors for numerous enzymatic reactions and physiological processes, supporting general health, immune function, and energy metabolism. Originally developed by Parke-Davis (a division of Pfizer), the brand is currently marketed and distributed by Petrus Pharmaceuticals in Australia. It is primarily used for the prevention and treatment of vitamin and mineral deficiencies in adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Myadec.